These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease? Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983 [TBL] [Abstract][Full Text] [Related]
4. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110 [TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy. Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978 [TBL] [Abstract][Full Text] [Related]
7. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements. Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related]
10. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L; J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913 [TBL] [Abstract][Full Text] [Related]
12. Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. Williams SB; Kacker R; Winston D; Bahnson E; Steele GS; Richie JP J Urol; 2011 Dec; 186(6):2245-8. PubMed ID: 22014805 [TBL] [Abstract][Full Text] [Related]
13. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383 [TBL] [Abstract][Full Text] [Related]
14. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. Weissbach L; Boedefeld EA J Urol; 1987 Jul; 138(1):77-82. PubMed ID: 3599225 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center. Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782 [TBL] [Abstract][Full Text] [Related]
16. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors. Beck SD; Foster RS; Bihrle R; Donohue JP Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165 [TBL] [Abstract][Full Text] [Related]
17. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870 [TBL] [Abstract][Full Text] [Related]
18. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors. Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792 [TBL] [Abstract][Full Text] [Related]